Information de reference pour ce titreAccession Number: | 00042192-201101000-00021.
|
Author: | Ruddy, Kathryn J. MD, MPH 1; Gelber, Shari MSW 1; Ginsburg, Elizabeth S. MD 2; Schapira, Lidia MD 3; Abusief, Mary E. MD 2; Meyer, Meghan E. BS 1; Partridge, Ann H. MD, MPH 1
|
Institution: | From the (1)Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; (2)Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA; and (3)Medical Oncology, Massachusetts General Hospital, Boston, MA.
|
Title: | |
Source: | Menopause. 18(1):105-108, January 2011.
|
Abstract: | Objective: Many young breast cancer survivors experience menopausal symptoms and feel concerned about infertility due to oncologic treatment. However, there has been little research to date comparing young survivors' concerns and symptoms with those of young women of the same age and gravidity in the general population.
Methods: We surveyed breast cancer survivors with regular menses after adjuvant chemotherapy and compared them with age-matched, gravidity-matched controls as part of a study to evaluate the effects of chemotherapy on ovarian reserve. All survivors were 1 year or more from diagnosis of early-stage breast cancer, without evidence of recurrence. The survey assessed menopausal symptoms and infertility concerns.
Results: The study was stopped after a planned interim analysis of the first 20 matched pairs revealed significantly diminished measures of ovarian reserve in survivors compared with controls. Mean age was 37 years for both groups (range, 31-43 y). Eighty percent of survivors and 25% of controls expressed some concern regarding fertility at the time of the survey (P = 0.001). Survivors were more likely to report bothersome menopausal symptoms than were controls (P = 0.05). An exploratory analysis revealed that menopausal symptoms were greatest in the survivors taking tamoxifen.
Conclusions: Young women who remained premenopausal after breast cancer chemotherapy expressed greater concern about fertility and reported more menopausal symptoms than did age- and gravidity-matched controls. This may have been due to cancer diagnosis or treatment, or it may reflect other differences between the survivors and controls in this study. Additional research is warranted to determine how to most effectively address fertility concerns and reduce symptom burden in this population.
(C)2011The North American Menopause Society
|
Author Keywords: | Hot flashes; Menopause, premature; Infertility; Anxiety.
|
References: | 1. Schover LR. Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility. J Clin Oncol 2008;26:753-758.
2. Nystedt M, Berglund G, Bolund C, Brandberg Y, Fornander T, Rutqvist LE. Randomized trial of adjuvant tamoxifen and/or goserelin in premenopausal breast cancer-self-rated physiological effects and symptoms. Acta Oncol 2000;39:959-968.
3. Loprinzi CL, Wolf SL, Barton DL, Laack NN. Symptom management in premenopausal patients with breast cancer. Lancet Oncol 2008;9:993-1001.
4. Wenzel LB, Fairclough DL, Brady MJ, et al. Age-related differences in the quality of life of breast carcinoma patients after treatment. Cancer 1999;86:1768-1774.
5. Partridge AH, Ruddy KJ. Fertility and adjuvant treatment in young women with breast cancer. Breast 2007;16:S175-S181.
6. Partridge AH, Gelber S, Peppercorn J, et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 2004;22:4174-4183.
7. Dunn J, Steginga SK. Young women's experience of breast cancer: defining young and identifying concerns. Psychooncology 2000;9:137-146.
8. Schover LR. Sexuality and body image in younger women with breast cancer. J Natl Cancer Inst Monogr 1994;16:177-182.
9. Partridge AH, Ruddy KJ, Gelber S, et al. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fertil Steril 2010;94:638-644.
10. Ganz PA, Day R, Ware JE, Redmond C, Fisher B. Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. J Natl Cancer Inst 1995;87:1372-1382.
11. Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE. Life after breast cancer: understanding women's health-related quality of life and sexual functioning. J Clin Oncol 1998;16:501-514.
12. Leining MG, Gelber S, Rosenberg R, Przypyszny M, Winer EP, Partridge AH. Menopausal-type symptoms in young breast cancer survivors. Ann Oncol 2006;17:1777-1782.
13. Day R, Ganz PA, Costantino JP, Cronin WM, Wickerham DL, Fisher B. Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Clin Oncol 1999;17:2659-2669.
14. Rosen A. Third-party reproduction and adoption in cancer patients. J Natl Cancer Inst Monogr 2005;34:91-93.
|
Language: | English.
|
Document Type: | Brief Reports.
|
Journal Subset: | Clinical Medicine. Health Professions.
|
ISSN: | 1072-3714
|
NLM Journal Code: | c5b, 9433353
|
DOI Number: | https://dx.doi.org/10.1097/gme.0...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |